Next, we analyzed cytokine secretion of peripheral blood CD4+, CD8+, and Vγ9Vδ2+ T cells during docetaxel or docetaxel combined with rocaltrol therapy in patients with NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.